Back
Goldman Sachs S&P 500 Premium Income ETF Vs. Bright Minds Biosciences, Inc. Industry Stock Comparison
Buy
57
GPIX
Goldman Sachs S&P 500 Premium Income ETF
Last Price:
$52.00
Seasonality Move:
-0.32%
Buy
64
DRUG
Bright Minds Biosciences, Inc.
Last Price:
$86.42
Seasonality Move:
-30.03%
Buy
57
Goldman Sachs S&P 500 Premium Income ETF (GPIX)
is a Buy
Is Goldman Sachs S&P 500 Premium Income ETF a Buy, Sell or Hold?
-
The current Goldman Sachs S&P 500 Premium Income ETF [GPIX] share price is $52.35. The Score for GPIX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
GPIX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
64
Bright Minds Biosciences, Inc. (DRUG)
is a Buy
Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?
-
The current Bright Minds Biosciences, Inc. [DRUG] share price is $93.99. The Score for DRUG is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
DRUG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GPIX Stock Price Chart
What is Goldman Sachs S&P 500 Premium Income ETF's stock price today?
-
The Goldman Sachs S&P 500 Premium Income ETF share price today is $52.35Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GPIX is experiencing slight buying pressure.
DRUG Stock Price Chart
What is Bright Minds Biosciences, Inc.'s stock price today?
-
The Bright Minds Biosciences, Inc. share price today is $93.99Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing slight buying pressure.
GPIX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 49.16 | Sell |
| Chaikin Money Flow: | 187200 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
DRUG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.78 | Buy |
| Relative Strength Index (14 RSI): | 76.13 | Buy |
| Chaikin Money Flow: | 147064 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
GPIX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 52.63 | Sell |
| 20-day SMA: | 52.28 | Buy |
| 50-day SMA: | 52.3 | Buy |
| 200-day SMA: | 49.58 | Buy |
| 8-day EMA: | 52.55 | Sell |
| 20-day EMA: | 52.45 | Sell |
| 50-day EMA: | 52.21 | Buy |
| 200-day EMA: | 50.52 | Buy |
DRUG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 84.53 | Buy |
| 20-day SMA: | 72.88 | Buy |
| 50-day SMA: | 64.83 | Buy |
| 200-day SMA: | 42.54 | Buy |
| 8-day EMA: | 84.37 | Buy |
| 20-day EMA: | 75.93 | Buy |
| 50-day EMA: | 66.06 | Buy |
| 200-day EMA: | 46.89 | Buy |
Goldman Sachs S&P 500 Premium Income ETF Earnings Growth & GPIX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $3.34 per share.
Goldman Sachs S&P 500 Premium Income ETF Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bright Minds Biosciences, Inc. Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||